Enveric Biosciences (ENVB) Tax Provisions (2010 - 2024)
Enveric Biosciences (ENVB) posted Tax Provisions of $7199.0 for Q4 2024, up 315.89% sequentially from $1731.0 in Q1 2024, and down 67.74% YoY from $22318.0 in Q1 2024.
Enveric Biosciences (ENVB) Tax Provisions (2010 - 2024) Analysis & Trends
Enveric Biosciences has reported Tax Provisions for 13 years, with the latest figure at $7199.0 in Q4 2024.
- Quarterly Tax Provisions fell 67.74% year-over-year to $7199.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $8930.0 (up 100.88% YoY) and the FY2025 annual result came in at -$1.8 million, down 20728.41% from the prior year.
- Tax Provisions advanced to $7199.0 in Q4 2024 per ENVB's latest filing, from $1731.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $22318.0 in Q4 2023 and troughed at -$1.1 million in Q3 2020.
- A 3-year average of -$140215.6 and a median of $7199.0 in 2024 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 170.14% in 2020, down 99124.84% in 2020.
- Over 3 years, Tax Provisions stood at -$1.1 million in 2020, then jumped by 102.11% to $22318.0 in 2023, then sank by 67.74% to $7199.0 in 2024.
- According to Business Quant data, Tax Provisions over the past three periods registered $7199.0, $1731.0, and $22318.0 for Q4 2024, Q1 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.31 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.90 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -90.33 Mn |
| 10 | Enveric Biosciences | 5.42 Mn | -2.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 7,199.00 |
| Mar 31, 2024 | 1,731.00 |
| Dec 31, 2023 | 22,318.00 |
| Sep 30, 2023 | 6,595.00 |
| Sep 30, 2020 | -1.06 Mn |
| Jun 30, 2020 | 17,485.00 |
| Mar 31, 2020 | 21,892.00 |
| Dec 31, 2019 | -2.65 Mn |
| Sep 30, 2019 | -1,067.00 |
| Jun 30, 2019 | 16,590.00 |
| Mar 31, 2019 | -31,211.00 |
| Dec 31, 2018 | -19.46 Mn |
| Sep 30, 2018 | 24,934.00 |
| Dec 31, 2017 | -2.39 Mn |
| Dec 31, 2016 | -258,886.00 |
| Mar 31, 2016 | 2,020.00 |
| Dec 31, 2015 | -43,489.00 |
| Sep 30, 2015 | -128,460.00 |
| Jun 30, 2015 | 43,489.00 |
| Mar 31, 2015 | 275.00 |